Cian McCourt

Cian is a partner and Head of the Corporate and M&A Group. Cian specialises in mergers and acquisitions, advising on public and private transactions as well as corporate finance and equity capital markets transactions.

Cian has experience advising on domestic and cross border transactions in a number of industries including the pharma/healthcare, financial services, energy and technology sectors as well as advising on corporate migrations, holding company structures, schemes of arrangement and cross border mergers. Cian has extensive experience in public M&A and has advised international clients and boards of directors on investing in Ireland and Irish based acquisitions including advising on some of the largest and most high-profile public transactions in Irish corporate history. Prior to joining Arthur Cox Cian was a partner in another leading Irish law firm and spent a number of years based in London and New York.

Relevant Experience

• Advising Brookfield on its recommended €1.89 billion acquisition of Hibernia REIT plc
• Advising Global Shares plc on its acquisition by JP Morgan
• Advising NYSE listed Angel Pond Holdings Corporation on its proposed “de-SPAC” transaction with MariaDB Corporation Ab
• Advising PRA Health Sciences Inc. on its $12bn acquisition by ICON plc
• Advising Aon plc on its recommended $80 billion all-share combination with Willis Towers Watson plc
• Advising Further Global Capital Management on its acquisition of AA Ireland
• Advising Allergan plc on its $63 billion merger with AbbVie
• Advising Mediahuis NV on its €145.6 million takeover of Independent News & Media plc
• Advising Aryzta A.G. on its €800 million underwritten rights issue and the resulting admission of shares on the SIX Swiss Exchange and Euronext Dublin
• Advising Praxair, Inc. on its $70 billion merger of equals with Linde A.G. and the admission of Linde plc to the NYSE and the main market in Frankfurt
• Advising Greencore Group plc on its sale of Greencore US for $1,075 million and related £509 million share repurchase/tender offer
• Advising Medtronic plc on its acquisition of Irish medtech firm Crospon Limited